{"id":"W4281800226","doi":"10.51731/cjht.2022.343","title":"Enfortumab Vedotin (Padcev)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Urothelial cancer; Drug; Anticancer drug; Internal medicine; Oncology; Cancer; Pharmacology; Political science","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001024009,0.0001614315,0.0002221622,0.0006114049,0.000136337,0.0006749427,0.000250444,0.000254864,0.005076115],"category_scores_gemma":[0.002103266,0.00004655437,0.0003626177,0.000715228,0.0001872373,0.0002983436,0.0002188111,0.0005758782,0.0003469728],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002246932,"about_ca_system_score_gemma":0.002962349,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01408817,"about_ca_topic_score_gemma":0.0438036,"domain_scores_codex":[0.9995427,0.0001718585,0.00003108101,0.00002866716,0.000185904,0.00003976683],"domain_scores_gemma":[0.9993113,0.0002495457,0.0001876811,0.00002116618,0.0001654163,0.00006491563],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008045373,0.00006999947,0.0026615,0.003218472,0.000262279,0.0001513234,0.00002366899,0.001427364,0.001200723,0.009269931,0.0325264,0.9483837],"study_design_scores_gemma":[0.0008464456,0.001203526,0.01585058,0.006209071,0.0006047527,0.001898404,0.0001188931,0.00186513,0.004446936,0.003964728,0.9629611,0.00003042931],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.049616,0.8436947,0.00457431,0.008905019,0.0006091796,0.0004731454,0.005021492,0.0001845774,0.08692164],"genre_scores_gemma":[0.5229232,0.4388963,0.006162956,0.002411358,0.0002458723,0.0002647417,0.003500259,0.00002995686,0.02556542],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01408817,"threshold_uncertainty_score":0.02801234,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3542821329863515,"score_gpt":0.4064495632101858,"score_spread":0.05216743022383435,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}